Kyle Amber to Autoimmune Diseases
This is a "connection" page, showing publications Kyle Amber has written about Autoimmune Diseases.
Connection Strength
10.227
-
Diversity in autoimmune blistering disease clinical trials: a systematic review. Int J Dermatol. 2023 10; 62(10):e561-e562.
Score: 0.862
-
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms. Front Immunol. 2022; 13:912876.
Score: 0.817
-
The Immunogenetics of Autoimmune Blistering Diseases. Adv Exp Med Biol. 2022; 1367:173-212.
Score: 0.789
-
Gene expression profiling of laminin a3-blocked keratinocytes reveals an immune-independent mechanism of blistering. Exp Dermatol. 2022 04; 31(4):615-621.
Score: 0.784
-
The risk of Pneumocystis pneumonia in patients of?autoimmune blistering disease-reply to letter entitled "Pemphigus management guidelines: A life-saving perspective". J Am Acad Dermatol. 2021 11; 85(5):e289.
Score: 0.764
-
Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS. Arch Dermatol Res. 2022 Nov; 314(9):921-928.
Score: 0.760
-
Disease-dependent Risk of Pneumocystis Pneumonia: The Case of Autoimmune Blistering Disease. Chest. 2020 12; 158(6):2704-2705.
Score: 0.732
-
Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. 2020 May; 59(5):520-524.
Score: 0.677
-
Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
Score: 0.630
-
Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert survey. Int J Dermatol. 2018 11; 57(11):e125-e126.
Score: 0.624
-
Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes. Nat Rev Dis Primers. 2018 02 22; 4:18012.
Score: 0.604
-
Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers. JAMA Dermatol. 2017 11 01; 153(11):1189-1190.
Score: 0.591
-
Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis. JAMA Dermatol. 2017 11 01; 153(11):1137-1141.
Score: 0.591
-
Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. J Am Acad Dermatol. 2015 Aug; 73(2):337-8.
Score: 0.506
-
A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant Malignancy. Lung. 2015 Aug; 193(4):593-6.
Score: 0.496